Hypertrophic obstructive cardiomyopathy: what, when, why, for whom?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hypertrophic obstructive cardiomyopathy: what, when, why, for whom?

Published:2018-02-09 Issue:4 Volume:53 Page:700-707
ISSN:1010-7940
Container-title:European Journal of Cardio-Thoracic Surgery
language:en
Short-container-title:

Author:

Mestres Carlos A¹²,Bartel Thomas³,Sorgente Antonio³,Müller Silvana⁴,Gruner Christiane⁵,Dearani Joseph⁶,Quintana Eduard⁷

Affiliation:

1. Department of Cardiovascular Surgery, Herzzentrum University Hospital Zürich, Zürich, Switzerland

2. Department of Cardiothoracic and Vascular Surgery, Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates

3. Department of Cardiology, Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates

4. Department of Internal Medicine, Cardiology, Tirol Kliniken, University of Innsbruck, Innsbruck, Austria

5. Department of Cardiology, Herzzentrum University Hospital Zürich, Zürich, Switzerland

6. Department of Cardiovascular Surgery, Mayo Clinic and Mayo Foundation, Rochester, MN, USA

7. Department of Cardiovascular Surgery, Hospital Clinic, University of Barcelona, Barcelona, Spain

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Link

http://academic.oup.com/ejcts/article-pdf/53/4/700/24274541/ezy020.pdf

Reference66 articles.

1. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary artery risk development in (young) adults;Maron;Circulation,1995

2. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC);Elliott;Eur Heart J,2014

3. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Gersh;J Thorac Cardiovasc Surg,2011

4. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives;Maron;J Am Coll Cardiol,2012

5. Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy;Morrow;Ann Surg,1961

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transapical intramyocardial septal microwave ablation in treatment of hypertrophic obstructive cardiomyopathy: 12-month outcomes of a swine model;Journal of Cardiothoracic Surgery;2024-04-13

2. A Narrative Review of Emerging Therapies for Hypertrophic Obstructive Cardiomyopathy;Current Cardiology Reviews;2023-07

3. ГИПЕРТРОФИЯЛЫҚ КАРДИОМИОПАТИЯ – КӨП ҚЫРЛЫ МӘСЕЛЕНІҢ ҚАЗІРГІ ЖАҒДАЙЫ;Vestnik;2022-10-19

4. Acute myocardial infarction occurring after hypertrophic obstructive cardiomyopathy with paroxysmal atrial fibrillation: a case report;Journal of International Medical Research;2022-10

5. Surgical treatment of hypertrophic obstructive cardiomyopathy in relatively elderly patients: Short- and long-term outcomes;European Journal of Cardio-Thoracic Surgery;2022-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3